Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-27

Clinical Trial Update: Use of Botulinum Toxin in the Treatment of Androgenic Alopecia [Phase 2]

View source ↗

Summary

Phase 2 trial update on botulinum toxin for androgenetic alopecia (androgenetic alopecia) indicating ongoing status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Zel Skin and Laser Specialists | Conditions: Androgenetic Alopecia | Phase 2 | Status: ACTIVE_NOT_RECRUITING